Valsartan

  • The Problem: Many high blood pressure medications containing Valsartan have been found to have a substance in them that can cause cancer.

  • The Response: The FDA began a recall of many of these drugs in July, 2018. 

  • What Can We Do to Help: Our experienced attorneys can review your medical records and advise you if filing a case is in your best interest.

The attorneys at Gallon, Takacs, Boissoneault & Schaffer are investigating allegations that some blood pressure and heart failure drugs containing Valsartan have an added impurity that can cause cancer. If you or someone you know developed cancer after taking one of the contaminated drugs, contact us today. Find out if you can seek compensation for your injuries by completing our free case evaluation.

 

The FDA has recalled Valsartan due to claims the blood pressure and heart medication can be tainted with the known cancer-causing substances N-nitrosodimethylamine (NDMA) and/or N-Nitrosodiethylamine (NDEA).

There have been claims that Valsartan, a popular ingredient in many blood pressure and heart medications, has been contaminated with the known cancer-causing substances N-nitrosodimethylamine (NDMA) and/or N-Nitrosodiethylamine (NDEA). We are currently speaking with clients that may have cancer related to the use of these drugs.

In July 2018, the U.S. Food and Drug Administration (FDA) recalled of a number pharmaceutical drugs containing valsartan used to treat hypertension (high blood pressure) and heart failure due to the increased risk of certain cancers associated with NDMA. Not all drugs containing valsartan were named in the recall.

The following were named in the recall:

    • Major Pharmaceuticals valsartan products
    • Solco Healthcare valsartan products
    • Teva Pharmaceuticals Industries Ltd. valsartan products
    • Solco Healthcare valsartan/HCTZ products
    • Teva Pharmaceuticals Industries Ltd. valsartan/HCTZ products